Sternbach received his master's degree in pharmacy in 1929 and his doctoral degree in organic chemistry in 1931 from the
Jagiellonian University in Kraków. In 1937, he received a scholarship from Feliks-Wislicki Foundation. He moved to Vienna and then to
Zürich where he continued his research started in Kraków. In
Vienna he worked with Wolfgang Joseph Pauli, sr. and
Sigmund Fränkel, after which he worked with
Leopold Ružička at the
Swiss Federal Institute of Technology in Zurich. When war started, he was still in Switzerland. His mother, Hungarian born, survived hidden by Poles. While in
Basel on June 1, 1940, he joined
Hoffmann-La Roche, his employer until 2003. He married Herta Kreuzer. In 1941, he moved to the United States to work at Hoffmann-La Roche in
Nutley, New Jersey, thus escaping the Nazis. While working for Hoffmann-La Roche in Nutley, New Jersey, Sternbach worked on new drugs. He is credited with the discovery of
chlordiazepoxide (Librium),
diazepam (Valium),
flurazepam (Dalmane),
nitrazepam (Mogadon),
flunitrazepam (Rohypnol),
clonazepam (Klonopin), and
trimethaphan (Arfonad). Librium, based on the R0 6-690 compound discovered by Sternbach in 1956, was approved for use in 1960. In 1963, its improved version, Valium, was released and became very popular: between 1969 and 1982, it was the most prescribed drug in America, with over 2.3 billion doses sold in its peak year of 1978. With
Moses Wolf Goldberg, Sternbach also developed "the first commercially applicable" method for synthesizing
biotin. Sternbach held 241 patents, and his discoveries helped to turn Hoffmann-La Roche into a
pharmaceutical industry giant. He did not become wealthy from his discoveries, but he was happy; he treated chemistry as a passion and said, "I always did just what I wanted to do". He was active in his career until the age of 95. Sternbach was a longtime resident of
Upper Montclair, New Jersey, from 1943 to 2003. He then moved to
Chapel Hill, North Carolina, where he died in 2005. ==Legacy==